Document is current

Article History

Received: 27 October 2022

Revised: 11 April 2023

Accepted: 12 April 2023

First Online: 2 May 2023

Declarations

:

: All the authors except EB are employed by Beckman Coulter Life Sciences, USA. EB is currently employed by the Centers for Disease Control and Prevention, USA, but contributed to this work while previously employed by Beckman Coulter Life Sciences. Beckman Coulter Life Sciences funded this study.

: Origin 2022 and OriginPro 2022 (both produced by the OriginLab Corporation) have been used for the analyses of the raw data generated by the Beckman Coulter Inc. (“Beckman”) Analytical Ultracentrifuge. This third-party analysis software has not been validated by Beckman for use with the Beckman Analytical Ultracentrifuge. Beckman does not endorse any third-party analyses software. Beckman warranty and/or performance guarantee that may be applicable or are provided by Beckman for Beckman Analytical Ultracentrifuge do not apply to any third-party software. Copyright, License and Terms of Use Disclaimers are documented for the below software on their respective pages. OriginLab: .

: All products and services identified, unless noted as for in vitro diagnostic (IVD) use, are for research use and not intended or validated for use in the diagnosis of disease or other conditions. © 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks used herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.